David Della C, Layfield Robert, Serpell Louise, Narain Yolanda, Goedert Michel, Spillantini Maria Grazia
Cambridge Centre for Brain Repair and Neurology Department, University of Cambridge, Cambridge, UK.
J Neurochem. 2002 Oct;83(1):176-85. doi: 10.1046/j.1471-4159.2002.01137.x.
Filamentous inclusions composed of the microtubule-associated protein tau are a defining characteristic of a large number of neurodegenerative diseases. Here we show that tau degradation in stably transfected and non-transfected SH-SY5Y cells is blocked by the irreversible proteasome inhibitor lactacystin. Further, we find that in vitro, natively unfolded tau can be directly processed by the 20S proteasome without a requirement for ubiquitylation, and that a highly reproducible pattern of degradation intermediates is readily detectable during this process. Analysis of these intermediates shows that 20S proteasomal processing of tau is bi-directional, proceeding from both N- and C-termini, and that populations of relatively stable intermediates arise probably because of less efficient digestion of the C-terminal repeat region. Our results are consistent with an in vivo role for the proteasome in tau degradation and support the existence of ubiquitin-independent pathways for the proteasomal degradation of unfolded proteins.
由微管相关蛋白tau组成的丝状内含物是许多神经退行性疾病的一个决定性特征。在此我们表明,稳定转染和未转染的SH-SY5Y细胞中的tau降解被不可逆的蛋白酶体抑制剂乳胞素所阻断。此外,我们发现在体外,天然未折叠的tau可被20S蛋白酶体直接加工,无需泛素化,并且在此过程中很容易检测到高度可重复的降解中间体模式。对这些中间体的分析表明,tau的20S蛋白酶体加工是双向的,从N端和C端同时进行,并且相对稳定的中间体群体的出现可能是由于C端重复区域的消化效率较低。我们的结果与蛋白酶体在tau降解中的体内作用一致,并支持存在未折叠蛋白的蛋白酶体降解的非泛素依赖性途径。